BiondVax Pharmaceuticals (NASDAQ:BVXV) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a research report sent to investors on Thursday morning. The brokerage issued a hold rating on the stock. BiondVax Pharmaceuticals Stock Down 3.3 % Shares of BVXV stock opened at $1.31 on Thursday. The stock has a 50-day simple moving average of […]

Related Keywords

Israel , ,Exchange Commission ,Envestnet Asset Management Inc ,Biondvax Pharmaceuticals Stock Down ,Biondvax Pharmaceuticals ,Max Planck Society ,Biondvax Pharmaceuticals Ltd ,Institutional Trading Of Biondvax Pharmaceuticals ,Nasdaq ,News Ratings For Biondvax Pharmaceuticals Daily ,University Medical Center ,Biondvax Pharmaceuticals Company Profile ,Free Report ,Vax Pharmaceuticals Stock Down ,Vax Pharmaceuticals ,Get Free Report ,Asset Management ,Vax Pharmaceuticals Ltd ,Biondvax Pharmaceuticals Daily ,Nasdaq Bvxv ,Bvxv ,Medical ,Initiated Coverage ,Stocknews Com ,